ArticleFrontiers in oncology2021

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma.

Fahui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.